标普生物科技LOF(161127)
动态评分： 4.62分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2019-03-31 | ALNY | Alnylam Pharmaceuticals Inc | 194.25 | 1.6% |
| 2019-03-31 | ARRY | Array BioPharma Inc | 193.42 | 1.59% |
| 2019-03-31 | CELG | 新基 | 193.3 | 1.59% |
| 2019-03-31 | ICPT | Intercept Pharmaceuticals Inc | 191.84 | 1.58% |
| 2019-03-31 | PTLA | Portola Pharmaceuticals Inc | 186.9 | 1.54% |
| 2018-12-31 | ABBV | 艾伯维 | 175.2 | 1.45% |
| 2018-12-31 | FGEN | FibroGen Inc | 171.93 | 1.42% |
| 2018-12-31 | HRTX | Heron Therapeutics Inc | 168.99 | 1.39% |
| 2018-12-31 | IONS | Ionis Pharmaceuticals Inc | 166.14 | 1.37% |
| 2018-12-31 | MDGL | Madrigal Pharmaceuticals Inc | 166.33 | 1.37% |
| 2018-12-31 | PTCT | PTC Therapeutics Inc | 166.01 | 1.37% |
| 2018-12-31 | AMGN | 安进 | 164.87 | 1.36% |
| 2018-12-31 | LOXO | Loxo Oncology Inc | 164.1 | 1.35% |
| 2018-12-31 | TSRO | TESARO Inc | 163.94 | 1.35% |
| 2018-12-31 | UTHR | 联合治疗 | 164.2 | 1.35% |
| 2018-12-31 | NBIX | 神经分泌生物科学 | 162.81 | 1.34% |
| 2018-12-31 | PTLA | Portola Pharmaceuticals Inc | 162.09 | 1.34% |
| 2018-12-31 | LGND | Ligand Pharmaceuticals Inc | 161.31 | 1.33% |
| 2018-12-31 | REGN | 再生元制药 | 159.44 | 1.32% |
| 2018-12-31 | VRTX | 福泰制药 | 158.54 | 1.31% |
公告&资料